Literature DB >> 6725433

Effect of the calcium antagonist nimodipine on local cerebral blood flow: relationship to arterial blood pressure.

A A Mohamed, J McCulloch, A D Mendelow, G M Teasdale, A M Harper.   

Abstract

The effect of the calcium antagonist nimodipine on local CBF in 31 regions of the CNS was studied with the [14C]iodoantipyrine autoradiographic technique in lightly anaesthetised, mechanically ventilated rats. Continuous intravenous infusion of nimodipine (1, 2, or 4 micrograms kg-1 min-1) produced a dose-dependent reduction in MABP (reduced by 26 +/- 2% after 30 min of nimodipine, 4 micrograms kg-1 min-1) and a significant elevation in plasma glucose concentration (increased by 44 +/- 2% after 30 min of nimodipine, 4 micrograms kg-1 min-1). Local CBF was increased significantly during infusions of nimodipine (1 microgram kg-1 min-1) in 9 of the 31 regions examined (including the cerebral cortex, hippocampus, hypothalamus, and most thalamic nuclei). In contrast to the increases in CBF observed in forebrain regions, no significant increases in CBF were observed during nimodipine infusions in regions of the lower brainstem, cerebellum, and pons or in myelinated fibre tracts. The proportionately greatest increases in local CBF were observed during infusions of the lowest dosage of nimodipine (1 microgram kg-1 min-1), suggesting either that this dosage provokes maximum cerebrovascular relaxation or that effects of increasing concentrations are counteracted by the concomitant systemic hypotension.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725433     DOI: 10.1038/jcbfm.1984.29

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  11 in total

1.  Safety and efficacy of nimodipine in resuscitation of patients outside hospital.

Authors:  R O Roine; M Kaste; A Kinnunen; P Nikki
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

2.  Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.

Authors:  S M Gardiner; A M Compton; T Bennett; P A Kemp; U Ney
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

3.  Cerebrovascular autoregulation is resistant to calcium channel blockade with nimodipine.

Authors:  T A McCalden; R G Nath
Journal:  Experientia       Date:  1989-03-15

4.  Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat.

Authors:  P A Calle; M G Bogaert; L De Ridder; W A Buylaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

5.  Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors:  I Jansen; P Tfelt-Hansen; L Edvinsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Effects of emopamil on postischemic blood flow and neuronal damage in rat brain.

Authors:  G W Bielenberg; D Sauer; J Nuglisch; T Beck; C Rossberg; H D Mennel; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

8.  Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs.

Authors:  D J Duncker; J Heiligers; E J Mylecharane; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

Review 9.  Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.

Authors:  A N Wadworth; D McTavish
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

10.  Nimodipine has no effect on the cerebral circulation in conscious pigs, despite an increase in cardiac output.

Authors:  W J van der Giessen; D J Duncker; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.